Atara Biotherapeutics Inc. (ATRA) is priced at $15.66 after the most recent trading session. At the very opening of the session, the stock price was $17.90 and reached a high price of $17.97, prior to closing the session it reached the value of $17.98. The stock touched a low price of $15.34.Recently in News on October 13, 2021, Atara Biotherapeutics Presents New Magnetization Transfer Ratio Imaging Data and Two-Year Clinical Data from the Open Label Extension of ATA188 for Progressive Multiple Sclerosis at ECTRIMS 2021. Patients who Achieved Sustained Expanded Disability Status Scale (EDSS) Improvement at any Time Showed Significant Increase in Magnetization Transfer Ratio (MTR) from Baseline at 12 Months, Suggestive of Remyelination. You can read further details here
Atara Biotherapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $21.85 on 02/08/21, with the lowest value was $11.81 for the same time period, recorded on 08/20/21.
Atara Biotherapeutics Inc. (ATRA) full year performance was 10.91%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Atara Biotherapeutics Inc. shares are logging -44.47% during the 52-week period from high price, and 32.60% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $11.81 and $28.20.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1832805 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Atara Biotherapeutics Inc. (ATRA) recorded performance in the market was -20.22%, having the revenues showcasing 14.47% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.37B, as it employees total of 558 workers.
The Analysts eye on Atara Biotherapeutics Inc. (ATRA)
During the last month, 0 analysts gave the Atara Biotherapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 14.66, with a change in the price was noted +1.89. In a similar fashion, Atara Biotherapeutics Inc. posted a movement of +13.73% for the period of last 100 days, recording 790,444 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ATRA is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Atara Biotherapeutics Inc. (ATRA)
Raw Stochastic average of Atara Biotherapeutics Inc. in the period of last 50 days is set at 58.87%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 10.63%. In the last 20 days, the company’s Stochastic %K was 49.78% and its Stochastic %D was recorded 59.41%.
Considering, the past performance of Atara Biotherapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -20.22%. Additionally, trading for the stock in the period of the last six months notably improved by 12.34%, alongside a boost of 10.91% for the period of the last 12 months. The shares increased approximately by -10.05% in the 7-day charts and went down by 0.00% in the period of the last 30 days. Common stock shares were driven by 14.47% during last recorded quarter.